Full Text View
Tabular View
No Study Results Posted
Related Studies
The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Study NCT00451672   Information provided by National Taiwan University Hospital

First Received on March 22, 2007.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperaldosteronism
Hypertension
More general conditions related to this trial
Adrenal Gland Diseases
Adrenocortical Hyperfunction
Cardiovascular Diseases
Endocrine System Diseases
Vascular Diseases
Interventions listed in this trial
bromocriptine
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Agonists
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Taiwan University Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services